American Generics (India) Limited

American Generics (India) Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24239TG1995PLC020046 Incorporated 19 April 1995 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹30.24 Lakh
▲ 33.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹26.76 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
31 yrs
Est. 1995
Last financials
Mar 2025
Balance sheet date

About American Generics (India) Limited

Data last updated: 08 March 2026

American Generics (India) Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 April 1995, the company has been in operation for over 31 years.

Registered with ROC Hyderabad under CIN U24239AP1995PTC020046.

Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹26.76 Lakh. It is led by directors including Sunil Srivastava and Venkatasubrahmanyan Ramakrishnan.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Flat No.301 Sri Rama Mountview Road No.2 Banjarahills Hyderabad, Telangana, India.

As per the financials filed for FY 2024, the company reported a revenue of ₹30.24 Lakh, a growth of 33% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of American Generics (India) Limited
CIN U24239TG1995PLC020046
Registration Number 020046
Incorporation Date 19 April 1995
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Flat No.301 Sri Rama Mountview Road No.2 Banjarahills Hyderabad, Telangana, India
  • Industry
    Pharma, Drug Formulation & Development
Company report
American Generics (India) Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full American Generics (India) Limited report

Financials, compliance, directors, charges, ownership and filings for American Generics (India) Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of American Generics (India) Limited

American Generics (India) Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG1995PLC020046, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24239TG1995PLC020046 Current
U24239AP1995PTC020046 Previous
U24239AP1995PLC020046 Previous

Business Activity of American Generics (India) Limited

American Generics (India) Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including management consultancy activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M3 Management consultancy activities Locked
Premium access

Business activity turnover details for American Generics (India) Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of American Generics (India) Limited

American Generics (India) Limited is currently managed by 4 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sunil Srivastava Director 19 Apr 1995 31 Years 3 Months Current
Venkatasubrahmanyan Ramakrishnan Managing Director 19 Apr 1995 31 Years 3 Months Current
Bhupendera Prashanth Ramakrishnan Director 28 May 2018 8 Years 1 Months Current
Lalitha Ramakrishnan Director 04 Jul 2001 25 Years 0 Months Current

Financials of American Generics (India) Limited FY 2025 filings available

American Generics (India) Limited reported revenue of ₹30.24 Lakh (up 33.00% YoY) for FY 2024.

Revenue · FY 2024
₹30.24 Lakh ▲ 33.00%
Premium access

Ten-year financial statements for American Generics (India) Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings American Generics (India) Limited

American Generics (India) Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at American Generics (India) Limited

View historical data on people associated with American Generics (India) Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for American Generics (India) Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of American Generics (India) Limited

Premium access

GST registrations and filing compliance for American Generics (India) Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for American Generics (India) Limited

Premium access

Credit ratings, litigation, and regulatory alerts for American Generics (India) Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by American Generics (India) Limited

Premium access

MSME payment history for American Generics (India) Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of American Generics (India) Limited

Premium access

Corporate group structure for American Generics (India) Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of American Generics (India) Limited

Premium access

MCA filings and documents for American Generics (India) Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on American Generics (India) Limited

Activity
30 Sep 2025
American Generics (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
American Generics (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
28 May 2018
Bhupendera Prashanth Ramakrishnan was appointed as a Director on 28 May 2018 & has been associated with this company since 8 years 1 month.
Directors
04 Jul 2001
Lalitha Ramakrishnan was appointed as a Director on 04 Jul 2001 & has been associated with this company since 25 years 17 days.
Directors
19 Apr 1995
Sunil Srivastava was appointed as a Director on 19 Apr 1995 & has been associated with this company since 31 years 3 months.
Directors
19 Apr 1995
Venkatasubrahmanyan Ramakrishnan was appointed as a Managing Director on 19 Apr 1995 & has been associated with this company since 31 years 3 months.

Frequently Asked Questions about American Generics (India) Limited

American Generics (India) Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 19 April 1995 (31+ years old) and is registered under CIN U24239TG1995PLC020046.

American Generics (India) Limited reported revenue of ₹30.24 Lakh for FY 2024 (up 33.00% YoY).

The current directors of American Generics (India) Limited are:

The primary industry of American Generics (India) Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

American Generics (India) Limited can be reached at the registered office: Flat No.301 Sri Rama Mountview Road No.2 Banjarahills Hyderabad, Telangana, India.

The authorised capital is ₹1 Cr, and the paid-up capital is ₹26.76 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available